scholarly article | Q13442814 |
P50 | author | Wenjun Chang | Q59691345 |
P2093 | author name string | Guang Yang | |
Jianxiang Wang | |||
Ki-Duk Song | |||
Timothy C Thompson | |||
Chengzhen Ren | |||
Salahaldin A Tahir | |||
Alexei Goltsov | |||
P2860 | cites work | Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells | Q21142682 |
Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis | Q22252898 | ||
Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of beta-catenin | Q24299047 | ||
Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way | Q28256465 | ||
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis | Q28258638 | ||
TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth | Q28262401 | ||
Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptor | Q28272038 | ||
Caveolin-1 down-regulation inhibits insulin-like growth factor-I receptor signal transduction in H9C2 rat cardiomyoblasts | Q28573519 | ||
Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma | Q28749106 | ||
Critical nodes in signalling pathways: insights into insulin action | Q29614735 | ||
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation | Q29618700 | ||
Insulin and insulin-like growth factor signalling in neoplasia | Q29619495 | ||
Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance | Q30479891 | ||
Caveolin; different roles for insulin signal? | Q33215749 | ||
Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity | Q33611142 | ||
GSK3: a multifaceted kinase in Wnt signaling | Q33712410 | ||
IGF-IR internalizes with Caveolin-1 and PTRF/Cavin in HaCat cells | Q33770174 | ||
Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression. | Q33921157 | ||
Caveolin-1: a tumor-promoting role in human cancer | Q34010128 | ||
Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. | Q34986770 | ||
Metabolic alterations and targeted therapies in prostate cancer | Q35401667 | ||
Rethinking WNT signaling | Q35710664 | ||
Caveolin-1 in oncogenic transformation, cancer, and metastasis | Q36030347 | ||
Roles and regulation of Wnt signaling and beta-catenin in prostate cancer | Q36197343 | ||
Multiplicity of the interactions of Wnt proteins and their receptors | Q36692201 | ||
Tumor suppressors and cell metabolism: a recipe for cancer growth | Q37390879 | ||
The role of caveolin-1 in prostate cancer: clinical implications. | Q37542947 | ||
Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription. | Q39329917 | ||
Insulin receptor expression by human prostate cancers | Q39941083 | ||
Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of beta-catenin signaling | Q39964386 | ||
Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells | Q40015373 | ||
Prostate cancer cells promote osteoblastic bone metastases through Wnts | Q40377933 | ||
Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice | Q40440532 | ||
Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer | Q40632123 | ||
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. | Q40817530 | ||
Role of plasmalemmal caveolae in signal transduction. | Q40835516 | ||
Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis | Q40864791 | ||
Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling | Q40866028 | ||
Modulation of caveolin-1 expression can affect signalling through the phosphatidylinositol 3-kinase/Akt pathway and cellular proliferation in response to insulin-like growth factor I. | Q42437942 | ||
Caveolin-1 loss of function accelerates glucose transporter 4 and insulin receptor degradation in 3T3-L1 adipocytes. | Q42800248 | ||
Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells? | Q42858457 | ||
Fasting glucose is a risk factor for breast cancer: a prospective study. | Q44217805 | ||
Serum insulin-like growth factors, insulin-like growth factor-binding protein-3, and risk of lung cancer death: a case-control study nested in the Japan Collaborative Cohort (JACC) Study | Q44763667 | ||
Caveolin, cholesterol and Ras signalling | Q58444240 | ||
Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells | Q64381953 | ||
Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker | Q73229791 | ||
Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation | Q73787446 | ||
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer | Q73893922 | ||
Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer | Q80620399 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostate cancer | Q181257 |
P304 | page(s) | 1900-1911 | |
P577 | publication date | 2013-01-09 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer | |
P478 | volume | 73 |
Q28534819 | Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer |
Q38373132 | Baseline and Longitudinal Plasma Caveolin-1 Level as a Biomarker in Active Surveillance for Early Stage Prostate Cancer. |
Q58573362 | Biglycan Regulates MG63 Osteosarcoma Cell Growth Through a LPR6/β-Catenin/IGFR-IR Signaling Axis |
Q31070165 | Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data |
Q91709247 | Caveolin-1 Y14 phosphorylation suppresses tumor growth while promoting invasion |
Q28072525 | Caveolin-1 in the regulation of cell metabolism: a cancer perspective |
Q37564733 | Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer |
Q24718293 | Caveolin-1 regulates lung cancer stem-like cell induction and p53 inactivation in carbon nanotube-driven tumorigenesis |
Q26782615 | Caveolin-1, a stress-related oncotarget, in drug resistance |
Q98778499 | Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer |
Q92410949 | Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer |
Q28547446 | Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer |
Q28383915 | Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo |
Q64069266 | MiR-1180 from bone marrow MSCs promotes cell proliferation and glycolysis in ovarian cancer cells via SFRP1/Wnt pathway |
Q42226744 | Milk's Role as an Epigenetic Regulator in Health and Disease |
Q47790660 | Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy. |
Q37537958 | Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches |
Q47710385 | Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cells |
Q37735226 | Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells |
Q34052780 | Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells |
Q37555367 | Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease. |
Q45419184 | The Glycolytic Switch in Tumors: How Many Players Are Involved? |
Q47379977 | The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas? |
Q57106364 | The regulatory pathways leading to stem-like cells underlie prostate cancer progression |
Q26766079 | The sweet trap in tumors: aerobic glycolysis and potential targets for therapy |
Q38263093 | WNT signaling: an emerging mediator of cancer cell metabolism? |
Q49798174 | Wnt Signaling and Its Impact on Mitochondrial and Cell Cycle Dynamics in Pluripotent Stem Cells |
Q38806302 | β-Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-κB Signaling Pathway |